EPI-589
- Generic Name
- EPI-589
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C14H19NO4
- CAS Number
- 1147883-03-1
- Unique Ingredient Identifier
- I4ZSB1Q2DU
- Background
EPI-589 is under investigation in clinical trial NCT02460679 (Safety and Biomarker Study of EPI-589 in Participants With Amyotrophic Lateral Sclerosis (ALS)).
- Associated Conditions
- -
- Associated Therapies
- -
Safety and Biomarker Study of EPI-589 in Participants With Amyotrophic Lateral Sclerosis (ALS)
- First Posted Date
- 2015-06-02
- Last Posted Date
- 2020-10-14
- Lead Sponsor
- PTC Therapeutics
- Target Recruit Count
- 19
- Registration Number
- NCT02460679
- Locations
- 🇺🇸
Cedar's Sinai, Los Angeles, California, United States
🇺🇸Providence Brain and Spine Institute ALS Center, Portland, Oregon, United States
🇺🇸California Pacific Medical Center, San Francisco, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath